Can AI Help Detect Cognitive Impairment?

Mild cognitive impairment (MCI) can be an early indicator of Alzheimer's disease or dementia, so identifying those with cognitive issues early could lead to interventions and better outcomes. But diagnosing MCI can be a long and difficult process, especially in rural areas where access to licensed neuropsychologists is limited.

To increase accessibility to cognitive assessments, a team of researchers at the University of Missouri created a portable system to efficiently measure multiple aspects of motor function. The device is simple and affordable, combining a depth camera, a force plate and an interface board.

The interdisciplinary team of Mizzou researchers includes Trent Guess, an associate professor in the College of Health Sciences, Jamie Hall, an associate teaching professor in the College of Health Sciences, and Praveen Rao, an associate professor in the College of Engineering. In a recent study, the team examined older adults, some of whom had MCI, and asked them to complete three activities: standing still, walking and standing up from a bench. The catch? Participants had to complete these activities while counting backwards in intervals of seven at the same time.

Based off their performance, which was captured by the new portable system, the data was fed into a machine learning model - a type of artificial intelligence - that accurately identified 83% of those in the study with MCI.

"The areas of the brain involved in cognitive impairment overlap with areas of the brain involved in motor function, so when one is diminished, the other is impacted as well," said Guess. "These can be very subtle differences in motor function related to balance and walking that our new device is able to detect but would go unnoticed through observation."

With the number of Americans with Alzheimer’s disease expected to more than double by 2060 according to the Centers for Disease Control and Prevention, the portable device has the potential to help millions of older adults given that MCI is one of the precursors to Alzheimer's and dementia.

"Alzheimer’s disease is a significant problem here in the U.S. We know that if we can identify people early, we can provide early intervention to halt or slow the progression of the disease," Hall said. "Only about 8% of people in the U.S. who are believed to have MCI receive a clinical diagnosis."

Hall added the team’s long-term goal is get the new portable system into various settings such as county health departments, assisted living facilities, community centers, physical therapy clinics and senior centers to allow for more screenings.

"There are new drugs coming out to treat those with MCI, but you need a diagnosis of MCI to qualify for the medications," Hall said. "Our portable system can detect if a person walks slower or doesn’t take as big of a step because they are thinking very hard. Some people have more sway and are less balanced or are slower to stand up when they are sitting. Our technology can measure these subtle differences in a way that you could not with a stopwatch."

Guess will continue the research with additional participants and also look at the portable system’s ability to detect fall risk and frailty among older adults.

"This portable system has many other applications, too, including looking at those with concussions, sports rehabilitation, ALS and Parkinson’s disease, knee replacements and hip replacements," Guess said. "Moving is an important part of who we are. It’s rewarding to see that this portable system can be beneficial in a lot of different ways."

And those participating in the study are invested in the research, Hall added.

"Many of those who came in to be tested either have been diagnosed with MCI or have a family member who has Alzheimer’s disease, so they feel strongly about helping us move this forward," Hall said. "It really amplifies why this is so important to me."

Hall JB, Akter S, Rao P, Kiselica A, Ranum R, Thomas JM, Guess TM.
Feasibility of Using a Novel, Multimodal Motor Function Assessment Platform With Machine Learning to Identify Individuals With Mild Cognitive Impairment.
Alzheimer Dis Assoc Disord. 2024 Oct-Dec 01;38(4):344-350. doi: 10.1097/WAD.0000000000000646

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...